KR20230152008A

KR20230152008A - 단백질 m 유사체 및 융합 단백질 및 이들의 항체 기능 억제 용도

단백질 m 유사체 및 융합 단백질 및 이들의 항체 기능 억제 용도 Download PDF

Info

Publication number: KR20230152008A
Authority: KR; South Korea
Prior art keywords: protein; functional fragment; mycoplasma; subject; aav
Prior art date: 2021-02-03
Legal status : Pending

Application number

KR1020237028988A

Other languages

English (en)

Korean (ko)

Inventor

찰스 어스큐

청원 리

브라이언 쿨맨

데이비드 포레스트 티에커

Original Assignee

더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐

Priority date

2021-02-03

Filing date

2022-02-03

Publication date

2023-11-02

2022-02-03 Application filed by 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 filed Critical 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐

2023-11-02 Publication of KR20230152008A publication Critical patent/KR20230152008A/ko

Status Pending legal-status Critical Current

Links

101710085938 Matrix protein Proteins 0.000 title claims abstract description 525
101710127721 Membrane protein Proteins 0.000 title claims abstract description 525
230000002401 inhibitory effect Effects 0.000 title claims abstract description 16
108020001507 fusion proteins Proteins 0.000 title claims description 103
102000037865 fusion proteins Human genes 0.000 title claims description 103
239000012634 fragment Substances 0.000 claims abstract description 242
238000000034 method Methods 0.000 claims abstract description 186
241000204031 Mycoplasma Species 0.000 claims abstract description 148
239000003795 chemical substances by application Substances 0.000 claims abstract description 116
238000006386 neutralization reaction Methods 0.000 claims abstract description 73
230000027455 binding Effects 0.000 claims abstract description 52
230000003472 neutralizing effect Effects 0.000 claims abstract description 52
150000007523 nucleic acids Chemical group 0.000 claims description 154
210000004027 cell Anatomy 0.000 claims description 150
108090000765 processed proteins & peptides Proteins 0.000 claims description 146
102000039446 nucleic acids Human genes 0.000 claims description 140
108020004707 nucleic acids Proteins 0.000 claims description 140
239000013598 vector Substances 0.000 claims description 133
102000004196 processed proteins & peptides Human genes 0.000 claims description 119
229920001184 polypeptide Polymers 0.000 claims description 114
108090000623 proteins and genes Proteins 0.000 claims description 114
102000004169 proteins and genes Human genes 0.000 claims description 87
230000035772 mutation Effects 0.000 claims description 84
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 71
210000002966 serum Anatomy 0.000 claims description 71
238000012546 transfer Methods 0.000 claims description 65
210000003205 muscle Anatomy 0.000 claims description 50
108060003951 Immunoglobulin Proteins 0.000 claims description 49
102000018358 immunoglobulin Human genes 0.000 claims description 49
102000040430 polynucleotide Human genes 0.000 claims description 49
108091033319 polynucleotide Proteins 0.000 claims description 49
239000002157 polynucleotide Substances 0.000 claims description 49
230000014509 gene expression Effects 0.000 claims description 48
238000003556 assay Methods 0.000 claims description 40
208000035475 disorder Diseases 0.000 claims description 38
239000013603 viral vector Substances 0.000 claims description 36
210000001519 tissue Anatomy 0.000 claims description 35
239000000427 antigen Substances 0.000 claims description 33
108091007433 antigens Proteins 0.000 claims description 33
102000036639 antigens Human genes 0.000 claims description 33
150000001413 amino acids Chemical class 0.000 claims description 32
241000202934 Mycoplasma pneumoniae Species 0.000 claims description 28
241000282414 Homo sapiens Species 0.000 claims description 26
241000204051 Mycoplasma genitalium Species 0.000 claims description 26
229940072221 immunoglobulins Drugs 0.000 claims description 26
150000001875 compounds Chemical class 0.000 claims description 24
210000002027 skeletal muscle Anatomy 0.000 claims description 23
238000011282 treatment Methods 0.000 claims description 22
239000002245 particle Substances 0.000 claims description 21
239000007787 solid Substances 0.000 claims description 21
238000012384 transportation and delivery Methods 0.000 claims description 21
238000002347 injection Methods 0.000 claims description 19
239000007924 injection Substances 0.000 claims description 19
238000003018 immunoassay Methods 0.000 claims description 18
210000000056 organ Anatomy 0.000 claims description 18
108020004705 Codon Proteins 0.000 claims description 17
230000001580 bacterial effect Effects 0.000 claims description 16
239000013612 plasmid Substances 0.000 claims description 16
210000001508 eye Anatomy 0.000 claims description 15
210000004165 myocardium Anatomy 0.000 claims description 14
102000009109 Fc receptors Human genes 0.000 claims description 12
108010087819 Fc receptors Proteins 0.000 claims description 12
238000012217 deletion Methods 0.000 claims description 12
230000037430 deletion Effects 0.000 claims description 12
238000001990 intravenous administration Methods 0.000 claims description 12
210000004185 liver Anatomy 0.000 claims description 12
108010026228 mRNA guanylyltransferase Proteins 0.000 claims description 12
208000023275 Autoimmune disease Diseases 0.000 claims description 11
241000588724 Escherichia coli Species 0.000 claims description 11
210000004556 brain Anatomy 0.000 claims description 11
230000004048 modification Effects 0.000 claims description 11
238000012986 modification Methods 0.000 claims description 11
102000004190 Enzymes Human genes 0.000 claims description 10
108090000790 Enzymes Proteins 0.000 claims description 10
241000204003 Mycoplasmatales Species 0.000 claims description 10
230000001154 acute effect Effects 0.000 claims description 10
208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 claims description 9
241000702421 Dependoparvovirus Species 0.000 claims description 9
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 8
125000000539 amino acid group Chemical group 0.000 claims description 8
238000010828 elution Methods 0.000 claims description 8
210000005260 human cell Anatomy 0.000 claims description 8
210000004962 mammalian cell Anatomy 0.000 claims description 8
102000005962 receptors Human genes 0.000 claims description 8
108020003175 receptors Proteins 0.000 claims description 8
238000002965 ELISA Methods 0.000 claims description 7
210000003719 b-lymphocyte Anatomy 0.000 claims description 7
238000010362 genome editing Methods 0.000 claims description 7
230000013595 glycosylation Effects 0.000 claims description 7
238000006206 glycosylation reaction Methods 0.000 claims description 7
210000003734 kidney Anatomy 0.000 claims description 7
238000004064 recycling Methods 0.000 claims description 7
210000002460 smooth muscle Anatomy 0.000 claims description 7
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 6
101710120037 Toxin CcdB Proteins 0.000 claims description 6
210000000188 diaphragm Anatomy 0.000 claims description 6
210000004072 lung Anatomy 0.000 claims description 6
238000002616 plasmapheresis Methods 0.000 claims description 6
238000001262 western blot Methods 0.000 claims description 6
239000002202 Polyethylene glycol Substances 0.000 claims description 5
230000000692 anti-sense effect Effects 0.000 claims description 5
238000006243 chemical reaction Methods 0.000 claims description 5
230000000295 complement effect Effects 0.000 claims description 5
210000002216 heart Anatomy 0.000 claims description 5
229920001223 polyethylene glycol Polymers 0.000 claims description 5
230000009467 reduction Effects 0.000 claims description 5
230000035945 sensitivity Effects 0.000 claims description 5
210000003491 skin Anatomy 0.000 claims description 5
230000000699 topical effect Effects 0.000 claims description 5
MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical class C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 4
241000894006 Bacteria Species 0.000 claims description 4
108091033409 CRISPR Proteins 0.000 claims description 4
238000010354 CRISPR gene editing Methods 0.000 claims description 4
108091006905 Human Serum Albumin Proteins 0.000 claims description 4
102000008100 Human Serum Albumin Human genes 0.000 claims description 4
102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 claims description 4
101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 claims description 4
241001135743 Mycoplasma penetrans Species 0.000 claims description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 4
229960002685 biotin Drugs 0.000 claims description 4
235000020958 biotin Nutrition 0.000 claims description 4
239000011616 biotin Substances 0.000 claims description 4
239000001913 cellulose Substances 0.000 claims description 4
229920002678 cellulose Polymers 0.000 claims description 4
229920001577 copolymer Polymers 0.000 claims description 4
238000001943 fluorescence-activated cell sorting Methods 0.000 claims description 4
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
230000000951 immunodiffusion Effects 0.000 claims description 4
238000007918 intramuscular administration Methods 0.000 claims description 4
239000002502 liposome Substances 0.000 claims description 4
210000000496 pancreas Anatomy 0.000 claims description 4
238000003127 radioimmunoassay Methods 0.000 claims description 4
210000000952 spleen Anatomy 0.000 claims description 4
241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 3
241000713666 Lentivirus Species 0.000 claims description 3
206010052779 Transplant rejections Diseases 0.000 claims description 3
241000700618 Vaccinia virus Species 0.000 claims description 3
201000004988 autoimmune vasculitis Diseases 0.000 claims description 3
230000008859 change Effects 0.000 claims description 3
238000002512 chemotherapy Methods 0.000 claims description 3
206010052015 cytokine release syndrome Diseases 0.000 claims description 3
238000006471 dimerization reaction Methods 0.000 claims description 3
210000000981 epithelium Anatomy 0.000 claims description 3
238000003119 immunoblot Methods 0.000 claims description 3
238000007917 intracranial administration Methods 0.000 claims description 3
238000007913 intrathecal administration Methods 0.000 claims description 3
230000011987 methylation Effects 0.000 claims description 3
238000007069 methylation reaction Methods 0.000 claims description 3
201000005328 monoclonal gammopathy of uncertain significance Diseases 0.000 claims description 3
230000026731 phosphorylation Effects 0.000 claims description 3
238000006366 phosphorylation reaction Methods 0.000 claims description 3
229920000642 polymer Polymers 0.000 claims description 3
230000004481 post-translational protein modification Effects 0.000 claims description 3
238000001556 precipitation Methods 0.000 claims description 3
238000007920 subcutaneous administration Methods 0.000 claims description 3
238000007910 systemic administration Methods 0.000 claims description 3
241000701161 unidentified adenovirus Species 0.000 claims description 3
241000701447 unidentified baculovirus Species 0.000 claims description 3
241001529453 unidentified herpesvirus Species 0.000 claims description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 2
IEJPPSMHUUQABK-UHFFFAOYSA-N 2,4-diphenyl-4h-1,3-oxazol-5-one Chemical compound O=C1OC(C=2C=CC=CC=2)=NC1C1=CC=CC=C1 IEJPPSMHUUQABK-UHFFFAOYSA-N 0.000 claims description 2
229920000936 Agarose Polymers 0.000 claims description 2
241000710929 Alphavirus Species 0.000 claims description 2
108090001008 Avidin Proteins 0.000 claims description 2
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 2
102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 2
229920002307 Dextran Polymers 0.000 claims description 2
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 2
101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 2
208000034578 Multiple myelomas Diseases 0.000 claims description 2
239000000020 Nitrocellulose Substances 0.000 claims description 2
239000004677 Nylon Substances 0.000 claims description 2
206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
108010090804 Streptavidin Proteins 0.000 claims description 2
208000033559 Waldenström macroglobulinemia Diseases 0.000 claims description 2
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims description 2
238000007818 agglutination assay Methods 0.000 claims description 2
230000002776 aggregation Effects 0.000 claims description 2
238000004220 aggregation Methods 0.000 claims description 2
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
238000011091 antibody purification Methods 0.000 claims description 2
239000011324 bead Substances 0.000 claims description 2
229920001222 biopolymer Polymers 0.000 claims description 2
230000004700 cellular uptake Effects 0.000 claims description 2
238000012875 competitive assay Methods 0.000 claims description 2
230000000447 dimerizing effect Effects 0.000 claims description 2
150000002148 esters Chemical class 0.000 claims description 2
238000012817 gel-diffusion technique Methods 0.000 claims description 2
239000011521 glass Substances 0.000 claims description 2
150000004676 glycans Chemical class 0.000 claims description 2
125000001165 hydrophobic group Chemical group 0.000 claims description 2
238000000760 immunoelectrophoresis Methods 0.000 claims description 2
238000010166 immunofluorescence Methods 0.000 claims description 2
230000002055 immunohistochemical effect Effects 0.000 claims description 2
238000011532 immunohistochemical staining Methods 0.000 claims description 2
238000001114 immunoprecipitation Methods 0.000 claims description 2
238000009169 immunotherapy Methods 0.000 claims description 2
239000003999 initiator Substances 0.000 claims description 2
150000002632 lipids Chemical class 0.000 claims description 2
229920001220 nitrocellulos Polymers 0.000 claims description 2
229920001778 nylon Polymers 0.000 claims description 2
230000000174 oncolytic effect Effects 0.000 claims description 2
TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims description 2
230000006320 pegylation Effects 0.000 claims description 2
229920002401 polyacrylamide Polymers 0.000 claims description 2
238000006116 polymerization reaction Methods 0.000 claims description 2
229920000193 polymethacrylate Chemical class 0.000 claims description 2
229920001282 polysaccharide Polymers 0.000 claims description 2
239000005017 polysaccharide Substances 0.000 claims description 2
230000020175 protein destabilization Effects 0.000 claims description 2
230000009145 protein modification Effects 0.000 claims description 2
230000005588 protonation Effects 0.000 claims description 2
238000001959 radiotherapy Methods 0.000 claims description 2
102200052207 rs199469623 Human genes 0.000 claims description 2
239000000377 silicon dioxide Substances 0.000 claims description 2
238000010911 splenectomy Methods 0.000 claims description 2
230000019635 sulfation Effects 0.000 claims description 2
238000005670 sulfation reaction Methods 0.000 claims description 2
OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 2
241001430294 unidentified retrovirus Species 0.000 claims description 2
206010020631 Hypergammaglobulinaemia benign monoclonal Diseases 0.000 claims 2
241000991587 Enterovirus C Species 0.000 claims 1
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 claims 1
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 claims 1
230000010933 acylation Effects 0.000 claims 1
238000005917 acylation reaction Methods 0.000 claims 1
230000021615 conjugation Effects 0.000 claims 1
230000000593 degrading effect Effects 0.000 claims 1
230000006126 farnesylation Effects 0.000 claims 1
238000004062 sedimentation Methods 0.000 claims 1
238000011200 topical administration Methods 0.000 claims 1
238000010798 ubiquitination Methods 0.000 claims 1
230000034512 ubiquitination Effects 0.000 claims 1
230000001965 increasing effect Effects 0.000 abstract description 18
239000000203 mixture Substances 0.000 abstract description 15
230000006472 autoimmune response Effects 0.000 abstract description 3
230000028709 inflammatory response Effects 0.000 abstract description 2
239000005089 Luciferase Substances 0.000 description 73
235000018102 proteins Nutrition 0.000 description 73
238000010361 transduction Methods 0.000 description 69
230000026683 transduction Effects 0.000 description 64
206010028980 Neoplasm Diseases 0.000 description 61
230000002163 immunogen Effects 0.000 description 44
108060001084 Luciferase Proteins 0.000 description 40
241000699670 Mus sp. Species 0.000 description 40
201000011510 cancer Diseases 0.000 description 39
108091030071 RNAI Proteins 0.000 description 36
210000000234 capsid Anatomy 0.000 description 36
230000009368 gene silencing by RNA Effects 0.000 description 36
201000010099 disease Diseases 0.000 description 33
235000001014 amino acid Nutrition 0.000 description 31
238000000338 in vitro Methods 0.000 description 29
241000125945 Protoparvovirus Species 0.000 description 28
229940024606 amino acid Drugs 0.000 description 28
230000003612 virological effect Effects 0.000 description 28
238000001727 in vivo Methods 0.000 description 27
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 24
230000000694 effects Effects 0.000 description 24
239000002953 phosphate buffered saline Substances 0.000 description 24
-1 Rep 68 Proteins 0.000 description 22
210000002414 leg Anatomy 0.000 description 21
241000702423 Adeno-associated virus - 2 Species 0.000 description 20
241001164825 Adeno-associated virus - 8 Species 0.000 description 20
108091026890 Coding region Proteins 0.000 description 20
238000007792 addition Methods 0.000 description 19
125000003729 nucleotide group Chemical group 0.000 description 19
108091028043 Nucleic acid sequence Proteins 0.000 description 18
230000028993 immune response Effects 0.000 description 18
239000002773 nucleotide Substances 0.000 description 18
125000003275 alpha amino acid group Chemical group 0.000 description 16
238000002474 experimental method Methods 0.000 description 16
230000006870 function Effects 0.000 description 16
241000699666 Mus <mouse, genus> Species 0.000 description 15
241000700605 Viruses Species 0.000 description 15
238000013459 approach Methods 0.000 description 15
210000003169 central nervous system Anatomy 0.000 description 14
238000010790 dilution Methods 0.000 description 14
239000012895 dilution Substances 0.000 description 14
239000013607 AAV vector Substances 0.000 description 12
102000004127 Cytokines Human genes 0.000 description 12
108090000695 Cytokines Proteins 0.000 description 12
108700028146 Genetic Enhancer Elements Proteins 0.000 description 12
230000000903 blocking effect Effects 0.000 description 12
238000004113 cell culture Methods 0.000 description 12
230000001404 mediated effect Effects 0.000 description 12
239000002609 medium Substances 0.000 description 12
238000002844 melting Methods 0.000 description 12
230000008018 melting Effects 0.000 description 12
210000002845 virion Anatomy 0.000 description 12
102100039939 Growth/differentiation factor 8 Human genes 0.000 description 11
108010056852 Myostatin Proteins 0.000 description 11
238000004519 manufacturing process Methods 0.000 description 11
239000013642 negative control Substances 0.000 description 11
230000001225 therapeutic effect Effects 0.000 description 11
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 10
230000004071 biological effect Effects 0.000 description 10
238000011534 incubation Methods 0.000 description 10
230000001939 inductive effect Effects 0.000 description 10
208000015181 infectious disease Diseases 0.000 description 10
108010059929 phospholamban Proteins 0.000 description 10
238000011533 pre-incubation Methods 0.000 description 10
238000006467 substitution reaction Methods 0.000 description 10
230000014616 translation Effects 0.000 description 10
230000010415 tropism Effects 0.000 description 10
241000725303 Human immunodeficiency virus Species 0.000 description 9
230000008901 benefit Effects 0.000 description 9
238000001415 gene therapy Methods 0.000 description 9
230000003993 interaction Effects 0.000 description 9
102000035118 modified proteins Human genes 0.000 description 9
108091005573 modified proteins Proteins 0.000 description 9
230000001105 regulatory effect Effects 0.000 description 9
238000013518 transcription Methods 0.000 description 9
230000035897 transcription Effects 0.000 description 9
241000283690 Bos taurus Species 0.000 description 8
108091003079 Bovine Serum Albumin Proteins 0.000 description 8
108010025020 Nerve Growth Factor Proteins 0.000 description 8
241000713311 Simian immunodeficiency virus Species 0.000 description 8
230000003110 anti-inflammatory effect Effects 0.000 description 8
239000012091 fetal bovine serum Substances 0.000 description 8
238000003780 insertion Methods 0.000 description 8
230000037431 insertion Effects 0.000 description 8
238000004806 packaging method and process Methods 0.000 description 8
239000000047 product Substances 0.000 description 8
230000001681 protective effect Effects 0.000 description 8
239000012679 serum free medium Substances 0.000 description 8
208000024891 symptom Diseases 0.000 description 8
238000013519 translation Methods 0.000 description 8
101100524324 Adeno-associated virus 2 (isolate Srivastava/1982) Rep78 gene Proteins 0.000 description 7
108020004414 DNA Proteins 0.000 description 7
102000007072 Nerve Growth Factors Human genes 0.000 description 7
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 7
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 7
239000000443 aerosol Substances 0.000 description 7
230000015572 biosynthetic process Effects 0.000 description 7
238000004422 calculation algorithm Methods 0.000 description 7
229940088598 enzyme Drugs 0.000 description 7
230000036039 immunity Effects 0.000 description 7
239000007788 liquid Substances 0.000 description 7
238000004020 luminiscence type Methods 0.000 description 7
238000005259 measurement Methods 0.000 description 7
239000003900 neurotrophic factor Substances 0.000 description 7
102000005681 phospholamban Human genes 0.000 description 7
238000013207 serial dilution Methods 0.000 description 7
101100524317 Adeno-associated virus 2 (isolate Srivastava/1982) Rep40 gene Proteins 0.000 description 6
101100524319 Adeno-associated virus 2 (isolate Srivastava/1982) Rep52 gene Proteins 0.000 description 6
241000282412 Homo Species 0.000 description 6
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
101100259224 Oryctolagus cuniculus SYPL2 gene Proteins 0.000 description 6
102000006308 Sarcoglycans Human genes 0.000 description 6
108010083379 Sarcoglycans Proteins 0.000 description 6
108700019146 Transgenes Proteins 0.000 description 6
108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 6
102000016966 beta-2 Adrenergic Receptors Human genes 0.000 description 6
230000000875 corresponding effect Effects 0.000 description 6
231100000673 dose–response relationship Toxicity 0.000 description 6
239000003937 drug carrier Substances 0.000 description 6
210000003414 extremity Anatomy 0.000 description 6
239000003102 growth factor Substances 0.000 description 6
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
229940079322 interferon Drugs 0.000 description 6
230000010076 replication Effects 0.000 description 6
239000000523 sample Substances 0.000 description 6
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
208000011580 syndromic disease Diseases 0.000 description 6
239000003981 vehicle Substances 0.000 description 6
101100524321 Adeno-associated virus 2 (isolate Srivastava/1982) Rep68 gene Proteins 0.000 description 5
108090000565 Capsid Proteins Proteins 0.000 description 5
102100023321 Ceruloplasmin Human genes 0.000 description 5
206010010904 Convulsion Diseases 0.000 description 5
108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 5
108700026244 Open Reading Frames Proteins 0.000 description 5
108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 5
102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 5
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
230000009286 beneficial effect Effects 0.000 description 5
UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 5
238000012575 bio-layer interferometry Methods 0.000 description 5
239000000872 buffer Substances 0.000 description 5
230000002458 infectious effect Effects 0.000 description 5
208000030159 metabolic disease Diseases 0.000 description 5
201000006938 muscular dystrophy Diseases 0.000 description 5
229910052759 nickel Inorganic materials 0.000 description 5
238000005457 optimization Methods 0.000 description 5
230000010412 perfusion Effects 0.000 description 5
239000013641 positive control Substances 0.000 description 5
238000000746 purification Methods 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
210000001525 retina Anatomy 0.000 description 5
241000712461 unidentified influenza virus Species 0.000 description 5
108010059616 Activins Proteins 0.000 description 4
102400000068 Angiostatin Human genes 0.000 description 4
108010079709 Angiostatins Proteins 0.000 description 4
241000283707 Capra Species 0.000 description 4
108010069091 Dystrophin Proteins 0.000 description 4
102400001047 Endostatin Human genes 0.000 description 4
108010079505 Endostatins Proteins 0.000 description 4
102000003951 Erythropoietin Human genes 0.000 description 4
108090000394 Erythropoietin Proteins 0.000 description 4
102000016970 Follistatin Human genes 0.000 description 4
108010014612 Follistatin Proteins 0.000 description 4
102000006575 G-Protein-Coupled Receptor Kinases Human genes 0.000 description 4
108010008959 G-Protein-Coupled Receptor Kinases Proteins 0.000 description 4
239000004471 Glycine Substances 0.000 description 4
208000026350 Inborn Genetic disease Diseases 0.000 description 4
102100026818 Inhibin beta E chain Human genes 0.000 description 4
102000000588 Interleukin-2 Human genes 0.000 description 4
108010002350 Interleukin-2 Proteins 0.000 description 4
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
208000019022 Mood disease Diseases 0.000 description 4
102000005157 Somatostatin Human genes 0.000 description 4
108010056088 Somatostatin Proteins 0.000 description 4
101710172711 Structural protein Proteins 0.000 description 4
239000000488 activin Substances 0.000 description 4
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 4
238000010171 animal model Methods 0.000 description 4
FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
230000006378 damage Effects 0.000 description 4
230000007812 deficiency Effects 0.000 description 4
230000002950 deficient Effects 0.000 description 4
206010015037 epilepsy Diseases 0.000 description 4
229940105423 erythropoietin Drugs 0.000 description 4
238000002594 fluoroscopy Methods 0.000 description 4
210000002683 foot Anatomy 0.000 description 4
238000009472 formulation Methods 0.000 description 4
239000000499 gel Substances 0.000 description 4
108091006104 gene-regulatory proteins Proteins 0.000 description 4
208000006454 hepatitis Diseases 0.000 description 4
230000000977 initiatory effect Effects 0.000 description 4
238000007912 intraperitoneal administration Methods 0.000 description 4
239000006166 lysate Substances 0.000 description 4
230000002132 lysosomal effect Effects 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
238000010899 nucleation Methods 0.000 description 4
208000030613 peripheral artery disease Diseases 0.000 description 4
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 4
230000002265 prevention Effects 0.000 description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
210000003314 quadriceps muscle Anatomy 0.000 description 4
230000007017 scission Effects 0.000 description 4
238000012216 screening Methods 0.000 description 4
230000028327 secretion Effects 0.000 description 4
238000002864 sequence alignment Methods 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 4
241000894007 species Species 0.000 description 4
239000000126 substance Substances 0.000 description 4
238000012360 testing method Methods 0.000 description 4
238000002054 transplantation Methods 0.000 description 4
229960005486 vaccine Drugs 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
241000271566 Aves Species 0.000 description 3
102000004506 Blood Proteins Human genes 0.000 description 3
108010017384 Blood Proteins Proteins 0.000 description 3
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 3
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 3
241000701931 Canine parvovirus Species 0.000 description 3
201000003883 Cystic fibrosis Diseases 0.000 description 3
206010012689 Diabetic retinopathy Diseases 0.000 description 3
102000001039 Dystrophin Human genes 0.000 description 3
208000010412 Glaucoma Diseases 0.000 description 3
102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 3
108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
206010019280 Heart failures Diseases 0.000 description 3
101000685712 Homo sapiens Protein S100-A1 Proteins 0.000 description 3
101000600434 Homo sapiens Putative uncharacterized protein encoded by MIR7-3HG Proteins 0.000 description 3
108010001336 Horseradish Peroxidase Proteins 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
102000004877 Insulin Human genes 0.000 description 3
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 3
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
108010001831 LDL receptors Proteins 0.000 description 3
206010023927 Lassa fever Diseases 0.000 description 3
102100024640 Low-density lipoprotein receptor Human genes 0.000 description 3
102000004083 Lymphotoxin-alpha Human genes 0.000 description 3
108090000542 Lymphotoxin-alpha Proteins 0.000 description 3
208000018737 Parkinson disease Diseases 0.000 description 3
241001494479 Pecora Species 0.000 description 3
108091000080 Phosphotransferase Proteins 0.000 description 3
102100023097 Protein S100-A1 Human genes 0.000 description 3
102100037401 Putative uncharacterized protein encoded by MIR7-3HG Human genes 0.000 description 3
102000014128 RANK Ligand Human genes 0.000 description 3
108010025832 RANK Ligand Proteins 0.000 description 3
208000007014 Retinitis pigmentosa Diseases 0.000 description 3
102000011265 Sarcospan Human genes 0.000 description 3
108050001531 Sarcospan Proteins 0.000 description 3
102220564325 TIR domain-containing adapter molecule 2_S16E_mutation Human genes 0.000 description 3
108010075653 Utrophin Proteins 0.000 description 3
102000011856 Utrophin Human genes 0.000 description 3
206010046851 Uveitis Diseases 0.000 description 3
101710185494 Zinc finger protein Proteins 0.000 description 3
102100023597 Zinc finger protein 816 Human genes 0.000 description 3
239000002253 acid Substances 0.000 description 3
108060000200 adenylate cyclase Proteins 0.000 description 3
102000030621 adenylate cyclase Human genes 0.000 description 3
QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 3
230000033115 angiogenesis Effects 0.000 description 3
239000002870 angiogenesis inducing agent Substances 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
230000001772 anti-angiogenic effect Effects 0.000 description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
239000002981 blocking agent Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
229940112869 bone morphogenetic protein Drugs 0.000 description 3
238000010205 computational analysis Methods 0.000 description 3
238000011161 development Methods 0.000 description 3
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 3
239000003814 drug Substances 0.000 description 3
210000002889 endothelial cell Anatomy 0.000 description 3
239000003623 enhancer Substances 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
102000034356 gene-regulatory proteins Human genes 0.000 description 3
208000016361 genetic disease Diseases 0.000 description 3
239000005090 green fluorescent protein Substances 0.000 description 3
231100000283 hepatitis Toxicity 0.000 description 3
238000003384 imaging method Methods 0.000 description 3
239000003018 immunosuppressive agent Substances 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
230000002757 inflammatory effect Effects 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
238000001361 intraarterial administration Methods 0.000 description 3
208000002780 macular degeneration Diseases 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
201000001441 melanoma Diseases 0.000 description 3
108020004999 messenger RNA Proteins 0.000 description 3
201000006417 multiple sclerosis Diseases 0.000 description 3
208000015122 neurodegenerative disease Diseases 0.000 description 3
210000002569 neuron Anatomy 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
239000008188 pellet Substances 0.000 description 3
239000008177 pharmaceutical agent Substances 0.000 description 3
102000020233 phosphotransferase Human genes 0.000 description 3
230000000750 progressive effect Effects 0.000 description 3
239000013608 rAAV vector Substances 0.000 description 3
238000000926 separation method Methods 0.000 description 3
229960000553 somatostatin Drugs 0.000 description 3
208000002320 spinal muscular atrophy Diseases 0.000 description 3
210000000130 stem cell Anatomy 0.000 description 3
239000000758 substrate Substances 0.000 description 3
230000032258 transport Effects 0.000 description 3
FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 2
OYIFNHCXNCRBQI-UHFFFAOYSA-N 2-aminoadipic acid Chemical compound OC(=O)C(N)CCCC(O)=O OYIFNHCXNCRBQI-UHFFFAOYSA-N 0.000 description 2
RDFMDVXONNIGBC-UHFFFAOYSA-N 2-aminoheptanoic acid Chemical compound CCCCCC(N)C(O)=O RDFMDVXONNIGBC-UHFFFAOYSA-N 0.000 description 2
108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 description 2
PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 description 2
101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
102000055025 Adenosine deaminases Human genes 0.000 description 2
208000017194 Affective disease Diseases 0.000 description 2
208000024827 Alzheimer disease Diseases 0.000 description 2
108010032595 Antibody Binding Sites Proteins 0.000 description 2
108020005544 Antisense RNA Proteins 0.000 description 2
239000004475 Arginine Substances 0.000 description 2
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 2
208000003174 Brain Neoplasms Diseases 0.000 description 2
125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
206010007559 Cardiac failure congestive Diseases 0.000 description 2
208000024172 Cardiovascular disease Diseases 0.000 description 2
108090000994 Catalytic RNA Proteins 0.000 description 2
102000053642 Catalytic RNA Human genes 0.000 description 2
102100022641 Coagulation factor IX Human genes 0.000 description 2
206010009944 Colon cancer Diseases 0.000 description 2
108091000069 Cystinyl Aminopeptidase Proteins 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
102000016607 Diphtheria Toxin Human genes 0.000 description 2
108010053187 Diphtheria Toxin Proteins 0.000 description 2
101100396994 Drosophila melanogaster Inos gene Proteins 0.000 description 2
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 2
241000283073 Equus caballus Species 0.000 description 2
208000024720 Fabry Disease Diseases 0.000 description 2
108010076282 Factor IX Proteins 0.000 description 2
108010054218 Factor VIII Proteins 0.000 description 2
102000001690 Factor VIII Human genes 0.000 description 2
208000015872 Gaucher disease Diseases 0.000 description 2
102000004547 Glucosylceramidase Human genes 0.000 description 2
108010017544 Glucosylceramidase Proteins 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 description 2
206010053185 Glycogen storage disease type II Diseases 0.000 description 2
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
108010051696 Growth Hormone Proteins 0.000 description 2
229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
101710154606 Hemagglutinin Proteins 0.000 description 2
102000016871 Hexosaminidase A Human genes 0.000 description 2
108010053317 Hexosaminidase A Proteins 0.000 description 2
208000017604 Hodgkin disease Diseases 0.000 description 2
208000021519 Hodgkin lymphoma Diseases 0.000 description 2
208000010747 Hodgkins lymphoma Diseases 0.000 description 2
101001040800 Homo sapiens Integral membrane protein GPR180 Proteins 0.000 description 2
101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 2
244000309467 Human Coronavirus Species 0.000 description 2
241000702617 Human parvovirus B19 Species 0.000 description 2
208000023105 Huntington disease Diseases 0.000 description 2
206010062767 Hypophysitis Diseases 0.000 description 2
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 2
102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 2
102000038455 IGF Type 1 Receptor Human genes 0.000 description 2
108010031794 IGF Type 1 Receptor Proteins 0.000 description 2
206010062016 Immunosuppression Diseases 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
102100021244 Integral membrane protein GPR180 Human genes 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 2
102000004388 Interleukin-4 Human genes 0.000 description 2
108090000978 Interleukin-4 Proteins 0.000 description 2
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
JUQLUIFNNFIIKC-YFKPBYRVSA-N L-2-aminopimelic acid Chemical compound OC(=O)[C@@H](N)CCCCC(O)=O JUQLUIFNNFIIKC-YFKPBYRVSA-N 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
206010058467 Lung neoplasm malignant Diseases 0.000 description 2
206010025323 Lymphomas Diseases 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
102100022430 Melanocyte protein PMEL Human genes 0.000 description 2
206010027476 Metastases Diseases 0.000 description 2
206010056886 Mucopolysaccharidosis I Diseases 0.000 description 2
241001529936 Murinae Species 0.000 description 2
101100403745 Mus musculus Myot gene Proteins 0.000 description 2
HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 2
YPIGGYHFMKJNKV-UHFFFAOYSA-N N-ethylglycine Chemical compound CC[NH2+]CC([O-])=O YPIGGYHFMKJNKV-UHFFFAOYSA-N 0.000 description 2
KSPIYJQBLVDRRI-UHFFFAOYSA-N N-methylisoleucine Chemical compound CCC(C)C(NC)C(O)=O KSPIYJQBLVDRRI-UHFFFAOYSA-N 0.000 description 2
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 2
102100028200 Ornithine transcarbamylase, mitochondrial Human genes 0.000 description 2
101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
108091007960 PI3Ks Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
108060005874 Parvalbumin Proteins 0.000 description 2
102000001675 Parvalbumin Human genes 0.000 description 2
208000007913 Pituitary Neoplasms Diseases 0.000 description 2
101710176177 Protein A56 Proteins 0.000 description 2
229940116193 Protein phosphatase inhibitor Drugs 0.000 description 2
102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
101710151532 Replicating protein Proteins 0.000 description 2
201000007737 Retinal degeneration Diseases 0.000 description 2
206010039491 Sarcoma Diseases 0.000 description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
208000027520 Somatoform disease Diseases 0.000 description 2
102000013275 Somatomedins Human genes 0.000 description 2
102100038803 Somatotropin Human genes 0.000 description 2
102000011971 Sphingomyelin Phosphodiesterase Human genes 0.000 description 2
108010061312 Sphingomyelin Phosphodiesterase Proteins 0.000 description 2
101800001271 Surface protein Proteins 0.000 description 2
108700012411 TNFSF10 Proteins 0.000 description 2
208000022292 Tay-Sachs disease Diseases 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
108090000190 Thrombin Proteins 0.000 description 2
108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
102000003425 Tyrosinase Human genes 0.000 description 2
108060008724 Tyrosinase Proteins 0.000 description 2
108020004417 Untranslated RNA Proteins 0.000 description 2
102000039634 Untranslated RNA Human genes 0.000 description 2
241001227561 Valgus Species 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
230000021736 acetylation Effects 0.000 description 2
238000006640 acetylation reaction Methods 0.000 description 2
208000009956 adenocarcinoma Diseases 0.000 description 2
206010064930 age-related macular degeneration Diseases 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
230000009435 amidation Effects 0.000 description 2
238000007112 amidation reaction Methods 0.000 description 2
208000007502 anemia Diseases 0.000 description 2
238000002617 apheresis Methods 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
210000004436 artificial bacterial chromosome Anatomy 0.000 description 2
210000001106 artificial yeast chromosome Anatomy 0.000 description 2
235000009582 asparagine Nutrition 0.000 description 2
229960001230 asparagine Drugs 0.000 description 2
230000006470 autoimmune attack Effects 0.000 description 2
230000004888 barrier function Effects 0.000 description 2
108010014063 beta-adrenergic receptor kinase inhibitory peptide Proteins 0.000 description 2
239000012148 binding buffer Substances 0.000 description 2
230000036760 body temperature Effects 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
210000004413 cardiac myocyte Anatomy 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
206010008118 cerebral infarction Diseases 0.000 description 2
210000001175 cerebrospinal fluid Anatomy 0.000 description 2
208000026106 cerebrovascular disease Diseases 0.000 description 2
210000004720 cerebrum Anatomy 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
238000004440 column chromatography Methods 0.000 description 2
239000003184 complementary RNA Substances 0.000 description 2
210000004087 cornea Anatomy 0.000 description 2
230000009260 cross reactivity Effects 0.000 description 2
230000001351 cycling effect Effects 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000007547 defect Effects 0.000 description 2
230000007850 degeneration Effects 0.000 description 2
YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 2
210000004443 dendritic cell Anatomy 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
VEVRNHHLCPGNDU-MUGJNUQGSA-O desmosine Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C(O)=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-O 0.000 description 2
238000001514 detection method Methods 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
229940079593 drug Drugs 0.000 description 2
210000005069 ears Anatomy 0.000 description 2
230000008030 elimination Effects 0.000 description 2
238000003379 elimination reaction Methods 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
210000002919 epithelial cell Anatomy 0.000 description 2
108700020302 erbB-2 Genes Proteins 0.000 description 2
230000007717 exclusion Effects 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
229960004222 factor ix Drugs 0.000 description 2
229960000301 factor viii Drugs 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000004927 fusion Effects 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
210000004602 germ cell Anatomy 0.000 description 2
229930195712 glutamate Natural products 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
201000004502 glycogen storage disease II Diseases 0.000 description 2
230000012010 growth Effects 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
239000000185 hemagglutinin Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
210000003016 hypothalamus Anatomy 0.000 description 2
230000002519 immonomodulatory effect Effects 0.000 description 2
230000009851 immunogenic response Effects 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
230000001506 immunosuppresive effect Effects 0.000 description 2
229940124589 immunosuppressive drug Drugs 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
230000010354 integration Effects 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
229940028885 interleukin-4 Drugs 0.000 description 2
238000002955 isolation Methods 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
238000012933 kinetic analysis Methods 0.000 description 2
210000005246 left atrium Anatomy 0.000 description 2
210000005240 left ventricle Anatomy 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
239000003446 ligand Substances 0.000 description 2
201000007270 liver cancer Diseases 0.000 description 2
208000014018 liver neoplasm Diseases 0.000 description 2
230000007774 longterm Effects 0.000 description 2
201000005202 lung cancer Diseases 0.000 description 2
208000020816 lung neoplasm Diseases 0.000 description 2
239000012139 lysis buffer Substances 0.000 description 2
230000001394 metastastic effect Effects 0.000 description 2
206010061289 metastatic neoplasm Diseases 0.000 description 2
239000002679 microRNA Substances 0.000 description 2
210000002161 motor neuron Anatomy 0.000 description 2
230000036457 multidrug resistance Effects 0.000 description 2
210000000663 muscle cell Anatomy 0.000 description 2
206010028417 myasthenia gravis Diseases 0.000 description 2
210000001577 neostriatum Anatomy 0.000 description 2
210000001328 optic nerve Anatomy 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
239000003934 phosphoprotein phosphatase inhibitor Substances 0.000 description 2
210000003635 pituitary gland Anatomy 0.000 description 2
230000008488 polyadenylation Effects 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
230000001566 pro-viral effect Effects 0.000 description 2
230000008569 process Effects 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
208000020016 psychiatric disease Diseases 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
230000004258 retinal degeneration Effects 0.000 description 2
230000002207 retinal effect Effects 0.000 description 2
108091092562 ribozyme Proteins 0.000 description 2
210000005245 right atrium Anatomy 0.000 description 2
210000005241 right ventricle Anatomy 0.000 description 2
229960004641 rituximab Drugs 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
238000000527 sonication Methods 0.000 description 2
210000000278 spinal cord Anatomy 0.000 description 2
230000006641 stabilisation Effects 0.000 description 2
238000011105 stabilization Methods 0.000 description 2
230000000087 stabilizing effect Effects 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
238000012916 structural analysis Methods 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000012385 systemic delivery Methods 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
230000035488 systolic blood pressure Effects 0.000 description 2
230000008685 targeting Effects 0.000 description 2
238000010257 thawing Methods 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
210000000115 thoracic cavity Anatomy 0.000 description 2
229960004072 thrombin Drugs 0.000 description 2
208000008732 thymoma Diseases 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
238000001890 transfection Methods 0.000 description 2
239000002753 trypsin inhibitor Substances 0.000 description 2
210000004881 tumor cell Anatomy 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
238000002255 vaccination Methods 0.000 description 2
210000003462 vein Anatomy 0.000 description 2
230000029812 viral genome replication Effects 0.000 description 2
210000004127 vitreous body Anatomy 0.000 description 2
230000003442 weekly effect Effects 0.000 description 2
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
BJBUEDPLEOHJGE-UHFFFAOYSA-N (2R,3S)-3-Hydroxy-2-pyrolidinecarboxylic acid Natural products OC1CCNC1C(O)=O BJBUEDPLEOHJGE-UHFFFAOYSA-N 0.000 description 1
BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 description 1
RWLSBXBFZHDHHX-VIFPVBQESA-N (2s)-2-(naphthalen-2-ylamino)propanoic acid Chemical compound C1=CC=CC2=CC(N[C@@H](C)C(O)=O)=CC=C21 RWLSBXBFZHDHHX-VIFPVBQESA-N 0.000 description 1
MRTPISKDZDHEQI-YFKPBYRVSA-N (2s)-2-(tert-butylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC(C)(C)C MRTPISKDZDHEQI-YFKPBYRVSA-N 0.000 description 1
HOZBSSWDEKVXNO-BXRBKJIMSA-N (2s)-2-azanylbutanedioic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CC(O)=O HOZBSSWDEKVXNO-BXRBKJIMSA-N 0.000 description 1
LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 1
HMLGSIZOMSVISS-ONJSNURVSA-N (7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(C=C)CSC21)C(O)=O)=O)C(=O)\C(=N/OCOC(=O)C(C)(C)C)C1=CSC(N)=N1 HMLGSIZOMSVISS-ONJSNURVSA-N 0.000 description 1
XABCFXXGZPWJQP-BYPYZUCNSA-N (S)-3-aminoadipic acid Chemical compound OC(=O)C[C@@H](N)CCC(O)=O XABCFXXGZPWJQP-BYPYZUCNSA-N 0.000 description 1
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
JHTPBGFVWWSHDL-UHFFFAOYSA-N 1,4-dichloro-2-isothiocyanatobenzene Chemical compound ClC1=CC=C(Cl)C(N=C=S)=C1 JHTPBGFVWWSHDL-UHFFFAOYSA-N 0.000 description 1
OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
GMKMEZVLHJARHF-UHFFFAOYSA-N 2,6-diaminopimelic acid Chemical compound OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
NYCRCTMDYITATC-UHFFFAOYSA-N 2-fluorophenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1F NYCRCTMDYITATC-UHFFFAOYSA-N 0.000 description 1
LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 1
XABCFXXGZPWJQP-UHFFFAOYSA-N 3-aminoadipic acid Chemical compound OC(=O)CC(N)CCC(O)=O XABCFXXGZPWJQP-UHFFFAOYSA-N 0.000 description 1
QCHPKSFMDHPSNR-UHFFFAOYSA-N 3-aminoisobutyric acid Chemical compound NCC(C)C(O)=O QCHPKSFMDHPSNR-UHFFFAOYSA-N 0.000 description 1
108010039636 3-isopropylmalate dehydrogenase Proteins 0.000 description 1
101800000504 3C-like protease Proteins 0.000 description 1
BMNBFRJBYVIOAY-UHFFFAOYSA-N 4,7,8-trihydroxy-3,4-dihydro-2h-isoquinolin-2-ium-1-one;chloride Chemical compound [Cl-].OC1=CC=C2C(O)C[NH2+]C(=O)C2=C1O BMNBFRJBYVIOAY-UHFFFAOYSA-N 0.000 description 1
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
WEOVIDNFPYIGBS-UHFFFAOYSA-N 4-aminobutanoic acid;piperidine-1-carboxylic acid Chemical compound NCCCC(O)=O.OC(=O)N1CCCCC1 WEOVIDNFPYIGBS-UHFFFAOYSA-N 0.000 description 1
XWHHYOYVRVGJJY-QMMMGPOBSA-N 4-fluoro-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-QMMMGPOBSA-N 0.000 description 1
101710144734 48 kDa protein Proteins 0.000 description 1
102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
OOXNYFKPOPJIOT-UHFFFAOYSA-N 5-(3-bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-amine;dihydrochloride Chemical compound Cl.Cl.C=12C(N)=NC=NC2=NC(C=2C=NC(=CC=2)N2CCOCC2)=CC=1C1=CC=CC(Br)=C1 OOXNYFKPOPJIOT-UHFFFAOYSA-N 0.000 description 1
ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
MJZJYWCQPMNPRM-UHFFFAOYSA-N 6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine Chemical compound CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC(Cl)=C(Cl)C=C1Cl MJZJYWCQPMNPRM-UHFFFAOYSA-N 0.000 description 1
SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
XGWFJBFNAQHLEF-UHFFFAOYSA-N 9-anthroic acid Chemical compound C1=CC=C2C(C(=O)O)=C(C=CC=C3)C3=CC2=C1 XGWFJBFNAQHLEF-UHFFFAOYSA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
206010000599 Acromegaly Diseases 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
102100036464 Activated RNA polymerase II transcriptional coactivator p15 Human genes 0.000 description 1
102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 description 1
241001655883 Adeno-associated virus - 1 Species 0.000 description 1
241000202702 Adeno-associated virus - 3 Species 0.000 description 1
241001634120 Adeno-associated virus - 5 Species 0.000 description 1
102100032534 Adenosine kinase Human genes 0.000 description 1
108010076278 Adenosine kinase Proteins 0.000 description 1
208000007848 Alcoholism Diseases 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
208000031277 Amaurotic familial idiocy Diseases 0.000 description 1
241000702419 Ambidensovirus Species 0.000 description 1
208000000103 Anorexia Nervosa Diseases 0.000 description 1
208000019901 Anxiety disease Diseases 0.000 description 1
241000712891 Arenavirus Species 0.000 description 1
102100032948 Aspartoacylase Human genes 0.000 description 1
108700023155 Aspartoacylases Proteins 0.000 description 1
206010003571 Astrocytoma Diseases 0.000 description 1
206010003591 Ataxia Diseases 0.000 description 1
102000007372 Ataxin-1 Human genes 0.000 description 1
108010032963 Ataxin-1 Proteins 0.000 description 1
208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
208000030767 Autoimmune encephalitis Diseases 0.000 description 1
206010003827 Autoimmune hepatitis Diseases 0.000 description 1
206010055128 Autoimmune neutropenia Diseases 0.000 description 1
102100035526 B melanoma antigen 1 Human genes 0.000 description 1
108700020463 BRCA1 Proteins 0.000 description 1
102000036365 BRCA1 Human genes 0.000 description 1
102000052609 BRCA2 Human genes 0.000 description 1
108700020462 BRCA2 Proteins 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
208000023328 Basedow disease Diseases 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
206010005003 Bladder cancer Diseases 0.000 description 1
201000004569 Blindness Diseases 0.000 description 1
208000019838 Blood disease Diseases 0.000 description 1
241000701922 Bovine parvovirus Species 0.000 description 1
102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
208000032841 Bulimia Diseases 0.000 description 1
206010006550 Bulimia nervosa Diseases 0.000 description 1
101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
238000011740 C57BL/6 mouse Methods 0.000 description 1
101150013553 CD40 gene Proteins 0.000 description 1
206010006895 Cachexia Diseases 0.000 description 1
102100035344 Cadherin-related family member 1 Human genes 0.000 description 1
101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 description 1
241000272834 Cairina moschata Species 0.000 description 1
102000004612 Calcium-Transporting ATPases Human genes 0.000 description 1
108010017954 Calcium-Transporting ATPases Proteins 0.000 description 1
208000022526 Canavan disease Diseases 0.000 description 1
102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
241000282465 Canis Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
208000020446 Cardiac disease Diseases 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
102100026548 Caspase-8 Human genes 0.000 description 1
108090000538 Caspase-8 Proteins 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
206010008342 Cervix carcinoma Diseases 0.000 description 1
102000000018 Chemokine CCL2 Human genes 0.000 description 1
241000684559 Chicken parvovirus Species 0.000 description 1
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
108700010070 Codon Usage Proteins 0.000 description 1
206010009900 Colitis ulcerative Diseases 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
206010010099 Combined immunodeficiency Diseases 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
206010010456 Congenital emphysema Diseases 0.000 description 1
241000711573 Coronaviridae Species 0.000 description 1
108700002856 Coronavirus Envelope Proteins Proteins 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
201000003075 Crimean-Congo hemorrhagic fever Diseases 0.000 description 1
208000011231 Crohn disease Diseases 0.000 description 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
108010036949 Cyclosporine Proteins 0.000 description 1
102000000311 Cytosine Deaminase Human genes 0.000 description 1
108010080611 Cytosine Deaminase Proteins 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
150000008574 D-amino acids Chemical class 0.000 description 1
208000027219 Deficiency disease Diseases 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
206010012239 Delusion Diseases 0.000 description 1
206010012289 Dementia Diseases 0.000 description 1
241000684283 Duck parvovirus Species 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
102100024108 Dystrophin Human genes 0.000 description 1
241001115402 Ebolavirus Species 0.000 description 1
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
102100038083 Endosialin Human genes 0.000 description 1
101710144543 Endosialin Proteins 0.000 description 1
101710121417 Envelope glycoprotein Proteins 0.000 description 1
102400001368 Epidermal growth factor Human genes 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000713730 Equine infectious anemia virus Species 0.000 description 1
241000121268 Erythroparvovirus Species 0.000 description 1
108010008165 Etanercept Proteins 0.000 description 1
HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
102100027186 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 description 1
108700001268 Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 description 1
206010016077 Factor IX deficiency Diseases 0.000 description 1
201000003542 Factor VIII deficiency Diseases 0.000 description 1
108010014173 Factor X Proteins 0.000 description 1
241000701915 Feline panleukopenia virus Species 0.000 description 1
241000701925 Feline parvovirus Species 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
NIGWMJHCCYYCSF-UHFFFAOYSA-N Fenclonine Chemical compound OC(=O)C(N)CC1=CC=C(Cl)C=C1 NIGWMJHCCYYCSF-UHFFFAOYSA-N 0.000 description 1
241000711950 Filoviridae Species 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
241000710831 Flavivirus Species 0.000 description 1
201000011240 Frontotemporal dementia Diseases 0.000 description 1
206010017533 Fungal infection Diseases 0.000 description 1
102100039717 G antigen 1 Human genes 0.000 description 1
101150117028 GP gene Proteins 0.000 description 1
101710177291 Gag polyprotein Proteins 0.000 description 1
102100028496 Galactocerebrosidase Human genes 0.000 description 1
108010042681 Galactosylceramidase Proteins 0.000 description 1
102400001370 Galanin Human genes 0.000 description 1
101800002068 Galanin Proteins 0.000 description 1
208000005577 Gastroenteritis Diseases 0.000 description 1
208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
208000022461 Glomerular disease Diseases 0.000 description 1
206010018364 Glomerulonephritis Diseases 0.000 description 1
229920002683 Glycosaminoglycan Polymers 0.000 description 1
208000024869 Goodpasture syndrome Diseases 0.000 description 1
241001517118 Goose parvovirus Species 0.000 description 1
208000015023 Graves' disease Diseases 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
241000696272 Gull adenovirus Species 0.000 description 1
241000702620 H-1 parvovirus Species 0.000 description 1
208000004547 Hallucinations Diseases 0.000 description 1
206010019196 Head injury Diseases 0.000 description 1
208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
208000031220 Hemophilia Diseases 0.000 description 1
208000009292 Hemophilia A Diseases 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
208000005176 Hepatitis C Diseases 0.000 description 1
208000028782 Hereditary disease Diseases 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 description 1
101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 1
101000737767 Homo sapiens Cadherin-related family member 1 Proteins 0.000 description 1
101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 1
101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 1
101000886137 Homo sapiens G antigen 1 Proteins 0.000 description 1
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 1
101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 description 1
101001123331 Homo sapiens Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Proteins 0.000 description 1
101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 description 1
101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 1
241000701806 Human papillomavirus Species 0.000 description 1
208000015178 Hurler syndrome Diseases 0.000 description 1
LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
206010020575 Hyperammonaemia Diseases 0.000 description 1
206010051151 Hyperviscosity syndrome Diseases 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
208000028622 Immune thrombocytopenia Diseases 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
101710189008 Immunoglobulin kappa light chain Proteins 0.000 description 1
102100029567 Immunoglobulin kappa light chain Human genes 0.000 description 1
102100037852 Insulin-like growth factor I Human genes 0.000 description 1
102100025947 Insulin-like growth factor II Human genes 0.000 description 1
102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
108010047761 Interferon-alpha Proteins 0.000 description 1
102000006992 Interferon-alpha Human genes 0.000 description 1
102000003996 Interferon-beta Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
102000003777 Interleukin-1 beta Human genes 0.000 description 1
108090000193 Interleukin-1 beta Proteins 0.000 description 1
102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 1
108700021006 Interleukin-1 receptor antagonist Proteins 0.000 description 1
102000003814 Interleukin-10 Human genes 0.000 description 1
108090000174 Interleukin-10 Proteins 0.000 description 1
102000003815 Interleukin-11 Human genes 0.000 description 1
108090000177 Interleukin-11 Proteins 0.000 description 1
102000013462 Interleukin-12 Human genes 0.000 description 1
108010065805 Interleukin-12 Proteins 0.000 description 1
102000003816 Interleukin-13 Human genes 0.000 description 1
108090000176 Interleukin-13 Proteins 0.000 description 1
102000003810 Interleukin-18 Human genes 0.000 description 1
108090000171 Interleukin-18 Proteins 0.000 description 1
102000004125 Interleukin-1alpha Human genes 0.000 description 1
108010082786 Interleukin-1alpha Proteins 0.000 description 1
102000000646 Interleukin-3 Human genes 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
102100039897 Interleukin-5 Human genes 0.000 description 1
108010002616 Interleukin-5 Proteins 0.000 description 1
102000004889 Interleukin-6 Human genes 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
102100021592 Interleukin-7 Human genes 0.000 description 1
108010002586 Interleukin-7 Proteins 0.000 description 1
108090001007 Interleukin-8 Proteins 0.000 description 1
102000004890 Interleukin-8 Human genes 0.000 description 1
102000000585 Interleukin-9 Human genes 0.000 description 1
108010002335 Interleukin-9 Proteins 0.000 description 1
241000121270 Iteradensovirus Species 0.000 description 1
229940122245 Janus kinase inhibitor Drugs 0.000 description 1
241000710842 Japanese encephalitis virus Species 0.000 description 1
208000012659 Joint disease Diseases 0.000 description 1
108060005987 Kallikrein Proteins 0.000 description 1
102000001399 Kallikrein Human genes 0.000 description 1
208000008839 Kidney Neoplasms Diseases 0.000 description 1
208000028226 Krabbe disease Diseases 0.000 description 1
QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
101710093778 L-dopachrome tautomerase Proteins 0.000 description 1
QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
QEFRNWWLZKMPFJ-ZXPFJRLXSA-N L-methionine (R)-S-oxide Chemical compound C[S@@](=O)CC[C@H]([NH3+])C([O-])=O QEFRNWWLZKMPFJ-ZXPFJRLXSA-N 0.000 description 1
QEFRNWWLZKMPFJ-UHFFFAOYSA-N L-methionine sulphoxide Natural products CS(=O)CCC(N)C(O)=O QEFRNWWLZKMPFJ-UHFFFAOYSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
241000270322 Lepidosauria Species 0.000 description 1
108010013563 Lipoprotein Lipase Proteins 0.000 description 1
102100022119 Lipoprotein lipase Human genes 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
208000005777 Lupus Nephritis Diseases 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
101710096786 Lysosomal acid alpha-glucosidase Proteins 0.000 description 1
208000015439 Lysosomal storage disease Diseases 0.000 description 1
108700041567 MDR Genes Proteins 0.000 description 1
208000002569 Machado-Joseph Disease Diseases 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
208000030162 Maple syrup disease Diseases 0.000 description 1
241001115401 Marburgvirus Species 0.000 description 1
241000489861 Maximus Species 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
208000024556 Mendelian disease Diseases 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
108091092539 MiR-208 Proteins 0.000 description 1
108700011259 MicroRNAs Proteins 0.000 description 1
241000702321 Microvirus Species 0.000 description 1
206010049567 Miller Fisher syndrome Diseases 0.000 description 1
108091060568 Mir-133 microRNA precursor family Proteins 0.000 description 1
102000015728 Mucins Human genes 0.000 description 1
108010063954 Mucins Proteins 0.000 description 1
206010056893 Mucopolysaccharidosis VII Diseases 0.000 description 1
208000005647 Mumps Diseases 0.000 description 1
206010028289 Muscle atrophy Diseases 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
208000031888 Mycoses Diseases 0.000 description 1
PQNASZJZHFPQLE-LURJTMIESA-N N(6)-methyl-L-lysine Chemical compound CNCCCC[C@H](N)C(O)=O PQNASZJZHFPQLE-LURJTMIESA-N 0.000 description 1
OLNLSTNFRUFTLM-BYPYZUCNSA-N N-ethyl-L-asparagine Chemical compound CCN[C@H](C(O)=O)CC(N)=O OLNLSTNFRUFTLM-BYPYZUCNSA-N 0.000 description 1
OLNLSTNFRUFTLM-UHFFFAOYSA-N N-ethylasparagine Chemical compound CCNC(C(O)=O)CC(N)=O OLNLSTNFRUFTLM-UHFFFAOYSA-N 0.000 description 1
108010065338 N-ethylglycine Proteins 0.000 description 1
230000004988 N-glycosylation Effects 0.000 description 1
KSPIYJQBLVDRRI-WDSKDSINSA-N N-methyl-L-isoleucine Chemical compound CC[C@H](C)[C@H](NC)C(O)=O KSPIYJQBLVDRRI-WDSKDSINSA-N 0.000 description 1
AKCRVYNORCOYQT-YFKPBYRVSA-N N-methyl-L-valine Chemical compound CN[C@@H](C(C)C)C(O)=O AKCRVYNORCOYQT-YFKPBYRVSA-N 0.000 description 1
101150118742 NP gene Proteins 0.000 description 1
108091061960 Naked DNA Proteins 0.000 description 1
RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
102100028782 Neprilysin Human genes 0.000 description 1
108090000028 Neprilysin Proteins 0.000 description 1
102000015336 Nerve Growth Factor Human genes 0.000 description 1
208000028389 Nerve injury Diseases 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
208000029067 Neuromyelitis optica spectrum disease Diseases 0.000 description 1
208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 1
206010029333 Neurosis Diseases 0.000 description 1
208000014060 Niemann-Pick disease Diseases 0.000 description 1
102000008297 Nuclear Matrix-Associated Proteins Human genes 0.000 description 1
108010035916 Nuclear Matrix-Associated Proteins Proteins 0.000 description 1
108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
102000011931 Nucleoproteins Human genes 0.000 description 1
108010061100 Nucleoproteins Proteins 0.000 description 1
RMINQIRDFIBNLE-NNRWGFCXSA-N O-[N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosaminyl]-L-serine Chemical compound O1[C@H](OC[C@H](N)C(O)=O)[C@H](NC(=O)C)[C@@H](O)[C@@H](O)[C@H]1CO[C@@]1(C(O)=O)O[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C1 RMINQIRDFIBNLE-NNRWGFCXSA-N 0.000 description 1
230000004989 O-glycosylation Effects 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
208000021384 Obsessive-Compulsive disease Diseases 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
206010033128 Ovarian cancer Diseases 0.000 description 1
206010061535 Ovarian neoplasm Diseases 0.000 description 1
108060006580 PRAME Proteins 0.000 description 1
102000036673 PRAME Human genes 0.000 description 1
239000002033 PVDF binder Substances 0.000 description 1
102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 description 1
108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
108091081548 Palindromic sequence Proteins 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
206010033661 Pancytopenia Diseases 0.000 description 1
241001631646 Papillomaviridae Species 0.000 description 1
241000282520 Papio Species 0.000 description 1
206010033864 Paranoia Diseases 0.000 description 1
208000027099 Paranoid disease Diseases 0.000 description 1
208000030852 Parasitic disease Diseases 0.000 description 1
241000701945 Parvoviridae Species 0.000 description 1
201000011152 Pemphigus Diseases 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
102100028960 Peroxisome proliferator-activated receptor gamma coactivator 1-alpha Human genes 0.000 description 1
201000005702 Pertussis Diseases 0.000 description 1
108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 1
102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 1
201000011252 Phenylketonuria Diseases 0.000 description 1
229940122907 Phosphatase inhibitor Drugs 0.000 description 1
208000000609 Pick Disease of the Brain Diseases 0.000 description 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
241000223503 Platysma Species 0.000 description 1
208000000474 Poliomyelitis Diseases 0.000 description 1
201000009916 Postpartum depression Diseases 0.000 description 1
102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 description 1
208000032319 Primary lateral sclerosis Diseases 0.000 description 1
241000288906 Primates Species 0.000 description 1
108010057464 Prolactin Proteins 0.000 description 1
102100024819 Prolactin Human genes 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
102100035703 Prostatic acid phosphatase Human genes 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102000005569 Protein Phosphatase 1 Human genes 0.000 description 1
108010059000 Protein Phosphatase 1 Proteins 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
101710150114 Protein rep Proteins 0.000 description 1
206010037075 Protozoal infections Diseases 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
208000006262 Psychological Sexual Dysfunctions Diseases 0.000 description 1
208000028017 Psychotic disease Diseases 0.000 description 1
ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
206010037779 Radiculopathy Diseases 0.000 description 1
241000700159 Rattus Species 0.000 description 1
101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
208000005587 Refsum Disease Diseases 0.000 description 1
206010038389 Renal cancer Diseases 0.000 description 1
101710152114 Replication protein Proteins 0.000 description 1
241000713124 Rift Valley fever virus Species 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
102100022135 S-arrestin Human genes 0.000 description 1
101710117586 S-arrestin Proteins 0.000 description 1
108010077895 Sarcosine Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
241000270295 Serpentes Species 0.000 description 1
101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 1
101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 1
244000191761 Sida cordifolia Species 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
208000021386 Sjogren Syndrome Diseases 0.000 description 1
201000001828 Sly syndrome Diseases 0.000 description 1
108091027967 Small hairpin RNA Proteins 0.000 description 1
108020004459 Small interfering RNA Proteins 0.000 description 1
241000425549 Snake parvovirus Species 0.000 description 1
102400000821 Somatostatin-28 Human genes 0.000 description 1
101800004701 Somatostatin-28 Proteins 0.000 description 1
108010019965 Spectrin Proteins 0.000 description 1
102000005890 Spectrin Human genes 0.000 description 1
208000009415 Spinocerebellar Ataxias Diseases 0.000 description 1
201000003622 Spinocerebellar ataxia type 2 Diseases 0.000 description 1
208000036834 Spinocerebellar ataxia type 3 Diseases 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
241000282887 Suidae Species 0.000 description 1
102000019197 Superoxide Dismutase Human genes 0.000 description 1
102000008221 Superoxide Dismutase-1 Human genes 0.000 description 1
108010021188 Superoxide Dismutase-1 Proteins 0.000 description 1
108010012715 Superoxide dismutase Proteins 0.000 description 1
102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 1
108700012920 TNF Proteins 0.000 description 1
102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 description 1
QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
108010017842 Telomerase Proteins 0.000 description 1
208000002903 Thalassemia Diseases 0.000 description 1
208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
UGPMCIBIHRSCBV-XNBOLLIBSA-N Thymosin beta 4 Chemical compound N([C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(C)=O UGPMCIBIHRSCBV-XNBOLLIBSA-N 0.000 description 1
102100035000 Thymosin beta-4 Human genes 0.000 description 1
239000004012 Tofacitinib Substances 0.000 description 1
208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 1
208000000323 Tourette Syndrome Diseases 0.000 description 1
208000016620 Tourette disease Diseases 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
206010044565 Tremor Diseases 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
108010027252 Trypsinogen Proteins 0.000 description 1
102000018690 Trypsinogen Human genes 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
206010054094 Tumour necrosis Diseases 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
206010053614 Type III immune complex mediated reaction Diseases 0.000 description 1
108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
102100027244 U4/U6.U5 tri-snRNP-associated protein 1 Human genes 0.000 description 1
101710155955 U4/U6.U5 tri-snRNP-associated protein 1 Proteins 0.000 description 1
108091026823 U7 small nuclear RNA Proteins 0.000 description 1
201000006704 Ulcerative Colitis Diseases 0.000 description 1
206010046298 Upper motor neurone lesion Diseases 0.000 description 1
208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
208000002495 Uterine Neoplasms Diseases 0.000 description 1
206010046865 Vaccinia virus infection Diseases 0.000 description 1
201000004810 Vascular dementia Diseases 0.000 description 1
206010063661 Vascular encephalopathy Diseases 0.000 description 1
206010047115 Vasculitis Diseases 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
101001001642 Xenopus laevis Serine/threonine-protein kinase pim-3 Proteins 0.000 description 1
241000710772 Yellow fever virus Species 0.000 description 1
229960003697 abatacept Drugs 0.000 description 1
210000001015 abdomen Anatomy 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
229960002964 adalimumab Drugs 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
201000009628 adenosine deaminase deficiency Diseases 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
238000009098 adjuvant therapy Methods 0.000 description 1
208000030597 adult Refsum disease Diseases 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
201000007930 alcohol dependence Diseases 0.000 description 1
108010030291 alpha-Galactosidase Proteins 0.000 description 1
102000005840 alpha-Galactosidase Human genes 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229960002684 aminocaproic acid Drugs 0.000 description 1
229960004238 anakinra Drugs 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
210000002159 anterior chamber Anatomy 0.000 description 1
210000000612 antigen-presenting cell Anatomy 0.000 description 1
230000036506 anxiety Effects 0.000 description 1
238000003491 array Methods 0.000 description 1
210000004507 artificial chromosome Anatomy 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
201000004339 autoimmune neuropathy Diseases 0.000 description 1
208000036556 autosomal recessive T cell-negative B cell-negative NK cell-negative due to adenosine deaminase deficiency severe combined immunodeficiency Diseases 0.000 description 1
229960002170 azathioprine Drugs 0.000 description 1
LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
210000004227 basal ganglia Anatomy 0.000 description 1
229960004669 basiliximab Drugs 0.000 description 1
230000006399 behavior Effects 0.000 description 1
WTOFYLAWDLQMBZ-LURJTMIESA-N beta(2-thienyl)alanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CS1 WTOFYLAWDLQMBZ-LURJTMIESA-N 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
229940000635 beta-alanine Drugs 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
230000008499 blood brain barrier function Effects 0.000 description 1
210000001218 blood-brain barrier Anatomy 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
210000004958 brain cell Anatomy 0.000 description 1
210000000133 brain stem Anatomy 0.000 description 1
229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
206010006451 bronchitis Diseases 0.000 description 1
229960004436 budesonide Drugs 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
229940046731 calcineurin inhibitors Drugs 0.000 description 1
244000309466 calf Species 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
238000002619 cancer immunotherapy Methods 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
239000000969 carrier Substances 0.000 description 1
101150038500 cas9 gene Proteins 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
230000003915 cell function Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
230000008614 cellular interaction Effects 0.000 description 1
210000001638 cerebellum Anatomy 0.000 description 1
229960003115 certolizumab pegol Drugs 0.000 description 1
201000010881 cervical cancer Diseases 0.000 description 1
210000003679 cervix uteri Anatomy 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
229960001265 ciclosporin Drugs 0.000 description 1
238000002983 circular dichroism Methods 0.000 description 1
229960002173 citrulline Drugs 0.000 description 1
235000013477 citrulline Nutrition 0.000 description 1
238000010367 cloning Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
230000002301 combined effect Effects 0.000 description 1
206010010121 compartment syndrome Diseases 0.000 description 1
238000010276 construction Methods 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
238000012937 correction Methods 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
201000003278 cryoglobulinemia Diseases 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
238000009109 curative therapy Methods 0.000 description 1
229930182912 cyclosporin Natural products 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
208000024389 cytopenia Diseases 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
229960002806 daclizumab Drugs 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000001934 delay Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
210000000852 deltoid muscle Anatomy 0.000 description 1
231100000868 delusion Toxicity 0.000 description 1
230000003210 demyelinating effect Effects 0.000 description 1
206010061811 demyelinating polyneuropathy Diseases 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
206010013023 diphtheria Diseases 0.000 description 1
208000037765 diseases and disorders Diseases 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
208000018459 dissociative disease Diseases 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000003182 dose-response assay Methods 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
201000010048 endomyocardial fibrosis Diseases 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
230000003511 endothelial effect Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
108700004025 env Genes Proteins 0.000 description 1
101150030339 env gene Proteins 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
102000015694 estrogen receptors Human genes 0.000 description 1
108010038795 estrogen receptors Proteins 0.000 description 1
229960000403 etanercept Drugs 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
230000017188 evasion or tolerance of host immune response Effects 0.000 description 1
229960005167 everolimus Drugs 0.000 description 1
231100000318 excitotoxic Toxicity 0.000 description 1
230000003492 excitotoxic effect Effects 0.000 description 1
210000001808 exosome Anatomy 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
208000030533 eye disease Diseases 0.000 description 1
229940012426 factor x Drugs 0.000 description 1
210000003195 fascia Anatomy 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
201000005206 focal segmental glomerulosclerosis Diseases 0.000 description 1
231100000854 focal segmental glomerulosclerosis Toxicity 0.000 description 1
230000022244 formylation Effects 0.000 description 1
238000006170 formylation reaction Methods 0.000 description 1
210000001652 frontal lobe Anatomy 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
229940044627 gamma-interferon Drugs 0.000 description 1
229940069042 gamunex Drugs 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
230000030279 gene silencing Effects 0.000 description 1
238000012226 gene silencing method Methods 0.000 description 1
238000010363 gene targeting Methods 0.000 description 1
230000009395 genetic defect Effects 0.000 description 1
210000004392 genitalia Anatomy 0.000 description 1
208000005017 glioblastoma Diseases 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
208000007345 glycogen storage disease Diseases 0.000 description 1
229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
229960001743 golimumab Drugs 0.000 description 1
210000002149 gonad Anatomy 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
210000003128 head Anatomy 0.000 description 1
230000036541 health Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
208000014951 hematologic disease Diseases 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
208000018706 hematopoietic system disease Diseases 0.000 description 1
208000007475 hemolytic anemia Diseases 0.000 description 1
210000003897 hepatic stem cell Anatomy 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
229940022353 herceptin Drugs 0.000 description 1
210000001320 hippocampus Anatomy 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
230000033444 hydroxylation Effects 0.000 description 1
238000005805 hydroxylation reaction Methods 0.000 description 1
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
229960002591 hydroxyproline Drugs 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
230000016178 immune complex formation Effects 0.000 description 1
230000003053 immunization Effects 0.000 description 1
102000028557 immunoglobulin binding proteins Human genes 0.000 description 1
108091009323 immunoglobulin binding proteins Proteins 0.000 description 1
230000028802 immunoglobulin-mediated neutralization Effects 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000011503 in vivo imaging Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
210000003552 inferior colliculi Anatomy 0.000 description 1
229960000598 infliximab Drugs 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000007689 inspection Methods 0.000 description 1
108700027921 interferon tau Proteins 0.000 description 1
229940076144 interleukin-10 Drugs 0.000 description 1
229940074383 interleukin-11 Drugs 0.000 description 1
229940117681 interleukin-12 Drugs 0.000 description 1
229940076264 interleukin-3 Drugs 0.000 description 1
229940100602 interleukin-5 Drugs 0.000 description 1
229940100601 interleukin-6 Drugs 0.000 description 1
229940100994 interleukin-7 Drugs 0.000 description 1
229940096397 interleukin-8 Drugs 0.000 description 1
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
229940118526 interleukin-9 Drugs 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
230000004410 intraocular pressure Effects 0.000 description 1
NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 1
229960004359 iodixanol Drugs 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
208000002551 irritable bowel syndrome Diseases 0.000 description 1
210000004153 islets of langerhan Anatomy 0.000 description 1
RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
229960005435 ixekizumab Drugs 0.000 description 1
210000001503 joint Anatomy 0.000 description 1
208000017476 juvenile neuronal ceroid lipofuscinosis Diseases 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
201000010982 kidney cancer Diseases 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
210000000629 knee joint Anatomy 0.000 description 1
108010008097 laminin alpha 2 Proteins 0.000 description 1
201000010901 lateral sclerosis Diseases 0.000 description 1
229960000681 leflunomide Drugs 0.000 description 1
VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 description 1
210000003715 limbic system Anatomy 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
239000006194 liquid suspension Substances 0.000 description 1
208000018191 liver inflammation Diseases 0.000 description 1
238000012153 long-term therapy Methods 0.000 description 1
238000009593 lumbar puncture Methods 0.000 description 1
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
210000005265 lung cell Anatomy 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
VWHRYODZTDMVSS-QMMMGPOBSA-N m-fluoro-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC(F)=C1 VWHRYODZTDMVSS-QMMMGPOBSA-N 0.000 description 1
229940124302 mTOR inhibitor Drugs 0.000 description 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
239000003628 mammalian target of rapamycin inhibitor Substances 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
208000024393 maple syrup urine disease Diseases 0.000 description 1
239000003550 marker Substances 0.000 description 1
239000012528 membrane Substances 0.000 description 1
210000001259 mesencephalon Anatomy 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
108091028606 miR-1 stem-loop Proteins 0.000 description 1
108091023685 miR-133 stem-loop Proteins 0.000 description 1
108091063796 miR-206 stem-loop Proteins 0.000 description 1
108091070501 miRNA Proteins 0.000 description 1
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
235000021243 milk fat Nutrition 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
SLZIZIJTGAYEKK-CIJSCKBQSA-N molport-023-220-247 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CNC=N1 SLZIZIJTGAYEKK-CIJSCKBQSA-N 0.000 description 1
239000000178 monomer Substances 0.000 description 1
208000005264 motor neuron disease Diseases 0.000 description 1
201000002273 mucopolysaccharidosis II Diseases 0.000 description 1
208000005340 mucopolysaccharidosis III Diseases 0.000 description 1
208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 1
208000011045 mucopolysaccharidosis type 3 Diseases 0.000 description 1
208000025919 mucopolysaccharidosis type 7 Diseases 0.000 description 1
238000002887 multiple sequence alignment Methods 0.000 description 1
208000010805 mumps infectious disease Diseases 0.000 description 1
201000000585 muscular atrophy Diseases 0.000 description 1
229940014456 mycophenolate Drugs 0.000 description 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
230000007498 myristoylation Effects 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
229960005027 natalizumab Drugs 0.000 description 1
210000000478 neocortex Anatomy 0.000 description 1
201000008383 nephritis Diseases 0.000 description 1
230000008764 nerve damage Effects 0.000 description 1
229940053128 nerve growth factor Drugs 0.000 description 1
210000001178 neural stem cell Anatomy 0.000 description 1
210000004498 neuroglial cell Anatomy 0.000 description 1
208000008795 neuromyelitis optica Diseases 0.000 description 1
201000007607 neuronal ceroid lipofuscinosis 3 Diseases 0.000 description 1
239000004090 neuroprotective agent Substances 0.000 description 1
208000015238 neurotic disease Diseases 0.000 description 1
230000005156 neurotropism Effects 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
210000000869 occipital lobe Anatomy 0.000 description 1
210000004248 oligodendroglia Anatomy 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
210000004409 osteocyte Anatomy 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
101800000607 p15 Proteins 0.000 description 1
239000006174 pH buffer Substances 0.000 description 1
208000027753 pain disease Diseases 0.000 description 1
201000002528 pancreatic cancer Diseases 0.000 description 1
208000008443 pancreatic carcinoma Diseases 0.000 description 1
230000003071 parasitic effect Effects 0.000 description 1
210000001152 parietal lobe Anatomy 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
244000052769 pathogen Species 0.000 description 1
210000000062 pectoralis major Anatomy 0.000 description 1
210000000989 pectoralis minor Anatomy 0.000 description 1
210000004197 pelvis Anatomy 0.000 description 1
201000001976 pemphigus vulgaris Diseases 0.000 description 1
210000002640 perineum Anatomy 0.000 description 1
210000001428 peripheral nervous system Anatomy 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
230000002688 persistence Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
239000008249 pharmaceutical aerosol Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
230000001830 phrenic effect Effects 0.000 description 1
210000004560 pineal gland Anatomy 0.000 description 1
230000001817 pituitary effect Effects 0.000 description 1
208000010916 pituitary tumor Diseases 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
108700004029 pol Genes Proteins 0.000 description 1
101150088264 pol gene Proteins 0.000 description 1
208000006473 polyradiculopathy Diseases 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
229960005205 prednisolone Drugs 0.000 description 1
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
229960004618 prednisone Drugs 0.000 description 1
XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
238000009609 prenatal screening Methods 0.000 description 1
230000013823 prenylation Effects 0.000 description 1
238000004321 preservation Methods 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
201000008752 progressive muscular atrophy Diseases 0.000 description 1
229940097325 prolactin Drugs 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
210000002307 prostate Anatomy 0.000 description 1
210000005267 prostate cell Anatomy 0.000 description 1
108010043671 prostatic acid phosphatase Proteins 0.000 description 1
230000009993 protective function Effects 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
230000012743 protein tagging Effects 0.000 description 1
238000009163 protein therapy Methods 0.000 description 1
210000002176 pterygoid muscle Anatomy 0.000 description 1
210000003689 pubic bone Anatomy 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
108010043277 recombinant soluble CD4 Proteins 0.000 description 1
230000000306 recurrent effect Effects 0.000 description 1
238000009256 replacement therapy Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
210000003994 retinal ganglion cell Anatomy 0.000 description 1
210000003583 retinal pigment epithelium Anatomy 0.000 description 1
230000007441 retrograde transport Effects 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
201000003068 rheumatic fever Diseases 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
210000000513 rotator cuff Anatomy 0.000 description 1
201000005404 rubella Diseases 0.000 description 1
238000009738 saturating Methods 0.000 description 1
201000000980 schizophrenia Diseases 0.000 description 1
229960004540 secukinumab Drugs 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000002924 silencing RNA Substances 0.000 description 1
229960002930 sirolimus Drugs 0.000 description 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
210000002363 skeletal muscle cell Anatomy 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
208000019116 sleep disease Diseases 0.000 description 1
239000004055 small Interfering RNA Substances 0.000 description 1
210000000329 smooth muscle myocyte Anatomy 0.000 description 1
101150005399 sod2 gene Proteins 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
208000020431 spinal cord injury Diseases 0.000 description 1
201000003624 spinocerebellar ataxia type 1 Diseases 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
210000001324 spliceosome Anatomy 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000003860 storage Methods 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
201000006152 substance dependence Diseases 0.000 description 1
208000011117 substance-related disease Diseases 0.000 description 1
210000003523 substantia nigra Anatomy 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
230000001839 systemic circulation Effects 0.000 description 1
201000000596 systemic lupus erythematosus Diseases 0.000 description 1
229960001967 tacrolimus Drugs 0.000 description 1
QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
101150047061 tag-72 gene Proteins 0.000 description 1
210000001587 telencephalon Anatomy 0.000 description 1
210000003478 temporal lobe Anatomy 0.000 description 1
210000001103 thalamus Anatomy 0.000 description 1
YSMODUONRAFBET-WHFBIAKZSA-N threo-5-hydroxy-L-lysine Chemical compound NC[C@@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-WHFBIAKZSA-N 0.000 description 1
230000002992 thymic effect Effects 0.000 description 1
108010079996 thymosin beta(4) Proteins 0.000 description 1
206010043778 thyroiditis Diseases 0.000 description 1
229960003989 tocilizumab Drugs 0.000 description 1
210000003371 toe Anatomy 0.000 description 1
229960001350 tofacitinib Drugs 0.000 description 1
UJLAWZDWDVHWOW-YPMHNXCESA-N tofacitinib Chemical compound C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)C1=NC=NC2=C1C=CN2 UJLAWZDWDVHWOW-YPMHNXCESA-N 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
BJBUEDPLEOHJGE-IMJSIDKUSA-N trans-3-hydroxy-L-proline Chemical compound O[C@H]1CC[NH2+][C@@H]1C([O-])=O BJBUEDPLEOHJGE-IMJSIDKUSA-N 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000011820 transgenic animal model Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
230000005740 tumor formation Effects 0.000 description 1
230000004222 uncontrolled growth Effects 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
201000005112 urinary bladder cancer Diseases 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
229960003824 ustekinumab Drugs 0.000 description 1
206010046766 uterine cancer Diseases 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
208000007089 vaccinia Diseases 0.000 description 1
239000004474 valine Substances 0.000 description 1
210000005167 vascular cell Anatomy 0.000 description 1
208000019553 vascular disease Diseases 0.000 description 1
210000005166 vasculature Anatomy 0.000 description 1
230000023898 viral genome packaging Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000002424 x-ray crystallography Methods 0.000 description 1
229940051021 yellow-fever virus Drugs 0.000 description 1